Literature DB >> 8395857

Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa.

K Brattegaard1, J Kouadio, M L Adom, R Doorly, J R George, K M De Cock.   

Abstract

OBJECTIVE: To evaluate a combination of rapid tests as a strategy for screening and supplemental testing of serum for HIV-1 and/or HIV-2 antibodies.
DESIGN: Cross-sectional evaluation.
SETTING: Projet RETRO-CI, an AIDS research project in Abidjan, Côte d'Ivoire.
METHODS: Serum specimens were collected from 1000 consecutive women giving birth in an Abidjan maternal and child health centre and from 185 hospitalized patients. All serum specimens were tested for HIV-1 and HIV-2 antibodies by whole-virus enzyme immunoassay; repeatedly reactive specimens were further tested by virus-specific Western blot and synthetic peptide-based tests. This was the reference strategy against which the algorithm under evaluation was compared. All specimens were subsequently tested by a mixed (HIV-1 and HIV-2) recombinant antigen-based test (Abbott Testpack), followed, if positive, by a rapid synthetic peptide-based test (Genetic Systems Genie) as a supplemental test.
RESULTS: According to the reference strategy the prevalence of HIV-1 and/or HIV-2 infection was 13% among the pregnant women and 78% among the hospitalized patients. Compared with the reference strategy, the combination of rapid tests was associated with a sensitivity of 99.6%, a specificity of 99.9%, and positive and negative predictive values of 99.6 and 99.9%, respectively. Four per cent of HIV-2-positive and 1% of HIV-1-positive specimens were considered dually reactive by the rapid test combination.
CONCLUSIONS: Synthetic peptide-based tests provide an alternative to Western blots for supplemental testing for HIV-1 and HIV-2. This combination of rapid tests offers performance characteristics comparable to an enzyme immunoassay and Western blot-based strategy, without requiring running water, electricity, or a well-developed laboratory. High-quality serodiagnosis of HIV-1 and HIV-2 infections is possible at the most peripheral levels of the health-care system in developing countries, the limiting factors being the costs of tests and training of staff.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Cross Sectional Analysis; Developing Countries; Diseases; Error Sources; Examinations And Diagnoses; False Negative Reactions; False Positive Reactions; French Speaking Africa; Hiv Infections; Hiv Serodiagnosis; Ivory Coast; Laboratory Examinations And Diagnoses; Measurement; Organization And Administration; Quality Control; Research Methodology; Research Report; Screening; Viral Diseases; Western Africa

Mesh:

Substances:

Year:  1993        PMID: 8395857     DOI: 10.1097/00002030-199306000-00019

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Use of rapid and conventional testing technologies for human immunodeficiency virus type 1 serologic screening in a rural Kenyan reference laboratory.

Authors:  Ginamarie Foglia; G Donald Royster; K Monique Wasunna; Rukia Kibaya; Jennifer A Malia; Eva K Calero; Warren Sateren; Philip O Renzullo; Merlin L Robb; Deborah L Birx; Nelson L Michael
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Simplified testing for antibodies to human immunodeficiency virus.

Authors:  P Pagcharoenpol; A Burgess-Cassler; W Schramm
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

3.  A simple whole-blood test for detecting antibodies to human immunodeficiency virus.

Authors:  W Schramm; S E Wade; G Barriga Angulo; P Castillo Torres; A Burgess-Cassler
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

4.  A field test for the detection of antibodies to human immunodeficiency virus types 1 and 2 in serum or plasma.

Authors:  A Burgess-Cassler; G Barriga Angulo; S E Wade; P Castillo Torres; W Schramm
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

Review 5.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

6.  Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests.

Authors:  S Phillips; T C Granade; C P Pau; D Candal; D J Hu; B S Parekh
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

7.  Rapid detection and differentiation of antibodies to HIV-1 and HIV-2 using multivalent antigens and magnetic immunochromatography testing.

Authors:  Timothy C Granade; Shon Workman; Susan K Wells; Angela N Holder; S Michele Owen; Chou-Pong Pau
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

8.  Improved HIV testing coverage after scale-up of antiretroviral therapy programs in urban Zambia: Evidence from serial hospital surveillance.

Authors:  Nzali G Kancheya; Atia K Jordan; Isaac S Zulu; Duncan Chanda; Sten H Vermund
Journal:  Med J Zambia       Date:  2010
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.